BETA
Your AI-Trained Oncology Knowledge Connection!
General Cancer
Stay up to date on practice-changing data in community practice.
Immunotherapy Duo Shows 42% 2-Year Survival in MSS CRC Trial
Agenus reveals promising survival rates for its immunotherapy in metastatic colorectal cancer, potentially transforming treatment for resistant patients.
Read More
Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia
In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan in breast cancer.
Listen
Evaluating Efficacy of Second-Line RCC Treatments Post-Immunotherapy
During a live event, Sumanta K. Pal, MD, discussed second-line renal cell carcinoma therapies, in the context of a patient with post-immunotherapy progression.
Juneja Explores AI’s Impact in Early Cancer Detection and Treatment
In this episode of Targeted Talks, Sanjay K. Juneja, MD, discusses the exciting advancements of artificial intelligence in 2024.
RAMP 201 Data Shows Advancements in Recurrent Low-Grade Serous Ovarian Cancer
Immunotherapy Advances and Challenges in T-Cell Lymphoma
Explore the latest advancements in immunotherapies for T-cell lymphoma, addressing unique challenges and promising new treatment options.
